DOCGO INC (DCGO) Stock Fundamental Analysis
NASDAQ:DCGO - Nasdaq - US2560861096 - Common Stock - Currency: USD
DCGO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While DCGO has a great health rating, there are worries on its profitability. DCGO has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year DCGO was profitable.
In the past year DCGO had a positive cash flow from operations.
DCGO had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DCGO reported negative operating cash flow in multiple years.
1.2 Ratios
DCGO's Return On Assets of -0.15% is in line compared to the rest of the industry. DCGO outperforms 47.06% of its industry peers.
The Return On Equity of DCGO (-0.21%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.15% | ||
| ROE | -0.21% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of DCGO has declined.
In the last couple of years the Operating Margin of DCGO has declined.
DCGO has a Gross Margin of 34.03%. This is in the better half of the industry: DCGO outperforms 64.71% of its industry peers.
DCGO's Gross Margin has been stable in the last couple of years.
DCGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.03% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
DCGO has less shares outstanding than it did 1 year ago.
The debt/assets ratio for DCGO is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.33 indicates that DCGO is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of DCGO (2.33) is comparable to the rest of the industry.
The Debt to FCF ratio of DCGO is 0.55, which is an excellent value as it means it would take DCGO, only 0.55 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DCGO (0.55) is better than 91.18% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that DCGO is not too dependend on debt financing.
DCGO has a Debt to Equity ratio of 0.13. This is in the better half of the industry: DCGO outperforms 72.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 2.33 |
ROIC/WACCN/A
WACC8.1%
2.3 Liquidity
DCGO has a Current Ratio of 2.44. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
DCGO's Current ratio of 2.44 is amongst the best of the industry. DCGO outperforms 84.31% of its industry peers.
DCGO has a Quick Ratio of 2.44. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.44, DCGO belongs to the top of the industry, outperforming 85.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.44 |
3. Growth
3.1 Past
The earnings per share for DCGO have decreased strongly by -65.00% in the last year.
The Earnings Per Share has been decreasing by -9.93% on average over the past years.
DCGO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -26.01%.
The Revenue has been growing by 24.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-65%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-190%
Revenue 1Y (TTM)-26.01%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
3.2 Future
The Earnings Per Share is expected to decrease by -35.00% on average over the next years. This is quite bad
DCGO is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -15.82% yearly.
EPS Next Y-124.19%
EPS Next 2Y-62.07%
EPS Next 3Y-35%
EPS Next 5YN/A
Revenue Next Year-49.7%
Revenue Next 2Y-27.64%
Revenue Next 3Y-15.82%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.71, DCGO is valued on the expensive side.
Based on the Price/Earnings ratio, DCGO is valued a bit cheaper than 66.67% of the companies in the same industry.
DCGO's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.31.
With a Price/Forward Earnings ratio of 38.77, DCGO can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCGO is on the same level as its industry peers.
DCGO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.13.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.71 | ||
| Fwd PE | 38.77 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCGO indicates a rather cheap valuation: DCGO is cheaper than 89.22% of the companies listed in the same industry.
DCGO's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DCGO is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.7 | ||
| EV/EBITDA | 6.1 |
4.3 Compensation for Growth
A cheap valuation may be justified as DCGO's earnings are expected to decrease with -35.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-62.07%
EPS Next 3Y-35%
5. Dividend
5.1 Amount
DCGO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.45
-0.06 (-3.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners59.61%
Inst Owner Change4.19%
Ins Owners6.96%
Ins Owner Change12.21%
Market Cap143.69M
Analysts78.46
Price Target3.11 (114.48%)
Short Float %5.64%
Short Ratio4.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-165.5%
Min EPS beat(2)-311.74%
Max EPS beat(2)-19.26%
EPS beat(4)1
Avg EPS beat(4)-84.64%
Min EPS beat(4)-311.74%
Max EPS beat(4)0.93%
EPS beat(8)2
Avg EPS beat(8)-66.93%
EPS beat(12)4
Avg EPS beat(12)-46.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.08%
Min Revenue beat(2)-9.68%
Max Revenue beat(2)-8.47%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)-0.57%
Revenue beat(8)4
Avg Revenue beat(8)0.9%
Revenue beat(12)7
Avg Revenue beat(12)1.96%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-39.6%
PT rev (3m)-41.27%
EPS NQ rev (1m)-376.95%
EPS NQ rev (3m)-583.2%
EPS NY rev (1m)-1337.53%
EPS NY rev (3m)-157.56%
Revenue NQ rev (1m)-22.53%
Revenue NQ rev (3m)-26.88%
Revenue NY rev (1m)-23.39%
Revenue NY rev (3m)-24.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.71 | ||
| Fwd PE | 38.77 | ||
| P/S | 0.28 | ||
| P/FCF | 1.7 | ||
| P/OCF | 1.59 | ||
| P/B | 0.46 | ||
| P/tB | 0.62 | ||
| EV/EBITDA | 6.1 |
EPS(TTM)0.07
EY4.83%
EPS(NY)0.04
Fwd EY2.58%
FCF(TTM)0.85
FCFY58.69%
OCF(TTM)0.91
OCFY63.07%
SpS5.25
BVpS3.12
TBVpS2.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.15% | ||
| ROE | -0.21% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.03% | ||
| FCFM | 16.2% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score5
Asset Turnover1.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 2.9 | ||
| Cap/Depr | 40.69% | ||
| Cap/Sales | 1.21% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 634.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.44 | ||
| Altman-Z | 2.33 |
F-Score5
WACC8.1%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-190%
EPS Next Y-124.19%
EPS Next 2Y-62.07%
EPS Next 3Y-35%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.01%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
Revenue Next Year-49.7%
Revenue Next 2Y-27.64%
Revenue Next 3Y-15.82%
Revenue Next 5YN/A
EBIT growth 1Y-102.46%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-89.9%
EBIT Next 3Y-27.25%
EBIT Next 5YN/A
FCF growth 1Y516.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y824.48%
OCF growth 3YN/A
OCF growth 5YN/A